Spindle checkpoint protein hMad2 and histone H3 phosphoserine 10 mitosis marker in pediatric solid tumors
1Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada. hidikio@ualberta.ca
Abstract:
Pediatric solid tumors of different histologic types are often treated with drugs (such as vincristine) that directly or indirectly target the mitotic spindle and the spindle checkpoint, leading to mitotic arrest, mitotic catastrophe and apoptosis. hMad2 (mitosis arrest deficient 2) expression in neuroblastoma has suggested utility in predicting prognosis. The present study was undertaken to determine hMad2 expression patterns in pediatric solid tumors, and its relationship to overall treatment response and short-term survival (2-years). The expression of hMad2 and histone H3-serine 10 phosphoprotein (mitosis marker) were examined using immunohistochemical staining methods in 26 pediatric solid tumors (six neuroblastomas, eight Wilm's, five sarcomas, four lymphomas and three hepatoblastomas). hMad2 expression paralleled overall histone H3 phosphoserine 10 expression in most tumor types. Low hMad2 score tumors (0-3.5) exhibited lower complete response (66.67%) and a higher recurrence/progressive disease (33.33%) than high score tumors (4-6) (78.57% and 21.43. %), consistent with predicted hMad2 function and reports in adult tumors. Histone H3 serine 10 phosphoprotein is useful in mitosis enumeration and hMad2 expression may provide additional help in neuroblastoma profiling and could be useful when spindle checkpoint specific target drugs are used.
Insights
Mitosis arrest deficient 2 (hMad2) expression in pediatric solid tumors correlates with treatment response. High hMad2 scores indicate better outcomes, suggesting its utility in predicting prognosis and guiding targeted therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Pediatric solid tumors often involve mitotic spindle targeting drugs.
- hMad2 (mitosis arrest deficient 2) shows prognostic potential in neuroblastoma.
- Understanding hMad2 in various pediatric tumors is crucial for treatment strategies.
Purpose of the Study:
- To investigate hMad2 expression patterns in diverse pediatric solid tumors.
- To correlate hMad2 expression with treatment response and 2-year survival.
- To assess the utility of hMad2 as a prognostic marker.
Main Methods:
- Immunohistochemical staining for hMad2 and histone H3-serine 10 phosphoprotein.
- Analysis of 26 pediatric solid tumors: neuroblastomas, Wilm's tumors, sarcomas, lymphomas, and hepatoblastomas.
- Correlation of hMad2 expression levels with treatment response and disease progression.
Main Results:
- hMad2 expression generally paralleled histone H3 phosphoserine 10 (mitosis marker) levels.
- Lower hMad2 scores were associated with reduced complete response rates (66.67%) and higher recurrence/progression (33.33%).
- Higher hMad2 scores correlated with better response (78.57%) and lower recurrence/progression (21.43%).
Conclusions:
- hMad2 expression is a potential prognostic indicator in pediatric solid tumors.
- hMad2 may aid in neuroblastoma profiling and patient stratification.
- hMad2 evaluation could be valuable for therapies targeting the spindle checkpoint.
Related Concept Videos
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Histone Variants at the Centromere
Abnormal Proliferation
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...


